Great Point Capital

Spyre Therapeutics is a biotechnology company focused on developing innovative antibody therapies aimed at transforming the treatment landscape for inflammatory bowel disease (IBD). By leveraging advanced antibody engineering, rational therapeutic combinations, and precision medicine strategies for patient selection, Spyre Therapeutics seeks to create next-generation products that address the chronic inflammation associated with IBD, which includes ulcerative colitis and Crohn's disease. The company aims to enhance existing treatment options, which currently include anti-inflammatory drugs, immunosuppressants, and biologics, thereby improving outcomes for patients suffering from these debilitating gastrointestinal disorders.

ABL Workspaces Private Limited, founded in 2017 and based in Delhi, India, operates a co-working space designed to foster collaboration among professionals from diverse backgrounds. The company provides a range of services that include well-equipped meeting rooms, comfortable workstations, and networking opportunities, all aimed at enhancing productivity and innovation. By offering essential amenities such as snacks and beverages, ABL Workspaces allows clients to concentrate on their work without the burdens of traditional office costs like rent and utilities. The environment encourages community building, enabling members to connect and grow together while pursuing their professional goals.

A b2b fintech marketplace connecting commercial property borrowers and lenders through a frictionless portal.